SAS and Carolina partner to accelerate antiviral drug development

Posted Nov 19, 2021
SAS, a leader in analytics and software services, and the University of North Carolina are teaming up to transform the drug development process to prevent infectious disease threats from turning into a pandemic like COVID-19. The partnership is focused on the work of the University’s Rapidly Emerging Antiviral Drug Development Initiative (READDI). (UNC.edu)

Related: Campus Connections

Pulled pork for pinstripes: How the Tar Heels and Hornets became the best-dressed teams in sports
"Having Dean Smith on the phone asking me for new Tar Heels uniforms was like having god asking for new hallows for the arch angles,"...
Fri Apr 11, 2025

DJ Nevy crafts the music behind UNC football and men's basketball
Nevy Ramadanovic's favorite part of UNC men's basketball games is when Associate Athletic Director Ken Cleary says three words. "Hot timeout, Nevy." It usually happens...
Wed Apr 9, 2025

UNC graduate programs ranked among best in nation
Numerous UNC-Chapel Hill graduate programs received high rankings — 24 were among the top 10 in the nation in their respective categories — as part...
Wed Apr 9, 2025

Hoops for Hunger collects food and hygiene items for western North Carolina
The sound of basketballs and roar of excited players filled Woollen Gym on a chilly January afternoon as teams of University of North Carolina community...
Tue Apr 8, 2025